Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
- PMID: 36589613
- PMCID: PMC9791549
- DOI: 10.46497/ArchRheumatol.2022.9217
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Abstract
Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls.
Patients and methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26±7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset ≤16 years) (2 males, 63 females; mean age: 23.4±7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay.
Results: Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p<0.01). A significant underexpression of factor H was observed in jSLE patients with nephritis compared to those without nephritis (p<0.03), while there was no association of factor H expression levels with any of the other clinical and serological features, disease activity or disease damage index of patients. Only 5% of jSLE patients were positive for factor H autoantibodies without any correlations with the clinical data or disease activity of patients.
Conclusion: Our study results suggest that factor H expression can be dysregulated in jSLE patients.
Keywords: Complement factor H; factor H autoantibodies; juvenile-onset systemic lupus erythematosus; nephritis..
Copyright © 2022, Turkish League Against Rheumatism.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Figures

Similar articles
-
Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.Arch Rheumatol. 2020 Jun 26;36(1):47-55. doi: 10.46497/ArchRheumatol.2021.8001. eCollection 2021 Mar. Arch Rheumatol. 2020. PMID: 34046568 Free PMC article.
-
Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study.Arch Rheumatol. 2021 Dec 24;37(2):280-287. doi: 10.46497/ArchRheumatol.2022.8888. eCollection 2022 Jun. Arch Rheumatol. 2021. PMID: 36017206 Free PMC article.
-
Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.Lupus. 2015 Oct;24(12):1342-9. doi: 10.1177/0961203315591024. Epub 2015 Jun 17. Lupus. 2015. PMID: 26085595
-
Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options.Clin Immunol. 2019 Dec;209:108274. doi: 10.1016/j.clim.2019.108274. Epub 2019 Oct 31. Clin Immunol. 2019. PMID: 31678365 Review.
-
Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus.Front Pediatr. 2019 May 9;7:149. doi: 10.3389/fped.2019.00149. eCollection 2019. Front Pediatr. 2019. PMID: 31143758 Free PMC article. Review.
References
-
- Hedrich CM, Smith EMD, Beresford MW. Juvenileonset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Pract Res Clin Rheumatol. 2017;31:488–504. - PubMed
-
- Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274–108274. - PubMed
-
- Eissa E, Morcos B, Abdelkawy RFM, Ahmed HH, Kholoussi NM. Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients. Lupus. 2021;30:1180–1187. - PubMed
-
- Davidson A, Aranow C. Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr Opin Rheumatol. 2006;18:468–475. - PubMed
-
- Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058–1066. - PubMed
LinkOut - more resources
Full Text Sources